Literature DB >> 18471465

Use of tissue Doppler to distinguish discrete upper ventricular septal hypertrophy from obstructive hypertrophic cardiomyopathy.

Annabel Chen-Tournoux1, Michael A Fifer, Michael H Picard, Judy Hung.   

Abstract

Discrete upper septal hypertrophy (DUSH) is a well-recognized but poorly understood echocardiographic finding that may indicate localized remodeling modulated by pressure loading or a forme fruste variant of obstructive hypertrophic cardiomyopathy (HC). It was hypothesized that (1) a comparison of tissue Doppler indexes of myocardial function in normal patients and those with DUSH or aortic stenosis (AS) could provide insight into the clinical significance of DUSH and (2) these indexes could distinguish between DUSH and obstructive HC. A retrospective analysis was performed on patients aged 50 to 80 years who underwent routine echocardiography and who could be classified into normal, DUSH, AS, and HC groups (n = 25, 33, 23, and 34, respectively) on the basis of clinical and echocardiographic criteria. Early diastolic mitral annular velocities (Ea) in the DUSH (7.1 +/- 1.8 cm/s) and AS (7.1 +/- 1.7 cm/s) groups were lower compared with those in the normal group (9.3 +/- 1.9 cm/s) and higher compared with those in the HC group (5.4 +/- 1.3 cm/s), whereas the E/Ea ratio was higher in the DUSH and AS groups (10.0 +/- 3.1 and 11.3 +/- 2.8, respectively) compared with the normal group (7.1 +/- 1.6) and lower compared with the HC group (18.8 +/- 7.5). These differences remained significant after adjusting for age and the use of beta blockers and calcium channel blockers. E/Ea > or =13 distinguished between patients with HC and those with DUSH (sensitivity 78%, specificity 90%, positive predictive value 90%, negative predictive value 81%). In conclusion, abnormal Ea and E/Ea in patients with DUSH, with values similar to those in patients with AS, suggest that DUSH may represent a variant hypertrophic response to chronic pressure loading. Simple echocardiographic indexes may be helpful in distinguishing between patients with DUSH and those with obstructive HC.

Entities:  

Mesh:

Year:  2008        PMID: 18471465     DOI: 10.1016/j.amjcard.2008.01.027

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging).

Authors:  Marco Canepa; Omar Malti; Melissa David; Majd AlGhatrif; James B Strait; Pietro Ameri; Claudio Brunelli; Edward G Lakatta; Luigi Ferrucci; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2014-06-19       Impact factor: 2.778

2.  Optimal Technique for Measurement of Linear Left Ventricular Dimensions.

Authors:  Michael Chetrit; Sébastien Roujol; Michael H Picard; Logan Timmins; Warren J Manning; Lawrence G Rudski; Robert A Levine; Jonathan Afilalo
Journal:  J Am Soc Echocardiogr       Date:  2019-02-28       Impact factor: 5.251

Review 3.  Looking for hypertrophic cardiomyopathy in the community: why is it important?

Authors:  Stefano Nistri; Iacopo Olivotto; Francesca Girolami; Francesca Torricelli; Franco Cecchi; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2009-10-20       Impact factor: 4.132

Review 4.  Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy.

Authors:  Valentin Fuster; Sarina van der Zee; Marc A Miller
Journal:  J Cardiovasc Transl Res       Date:  2009-10-16       Impact factor: 4.132

Review 5.  Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.

Authors:  Marco Canepa; Iraklis Pozios; Pier Filippo Vianello; Pietro Ameri; Claudio Brunelli; Luigi Ferrucci; Theodore P Abraham
Journal:  Heart       Date:  2016-04-27       Impact factor: 5.994

Review 6.  Basal septal hypertrophy.

Authors:  Mihir A Kelshiker; Jamil Mayet; Beth Unsworth; Darlington O Okonko
Journal:  Curr Cardiol Rev       Date:  2013-11

7.  Septal curvature as a robust and reproducible marker for basal septal hypertrophy.

Authors:  Maciej Marciniak; Andrew Gilbert; Filip Loncaric; Joao Filipe Fernandes; Bart Bijnens; Marta Sitges; Andrew King; Fatima Crispi; Pablo Lamata
Journal:  J Hypertens       Date:  2021-07-01       Impact factor: 4.776

8.  Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma.

Authors:  Takafumi Nakayama; Yoshiko Oshima; Yasuhiro Shintani; Junki Yamamoto; Masashi Yokoi; Tsuyoshi Ito; Kazuaki Wakami; Shuichi Kitada; Toshihiko Goto; Hiroya Hashimoto; Shigeru Kusumoto; Tomonori Sugiura; Shinsuke Iida; Yoshihiro Seo
Journal:  Circ Rep       Date:  2022-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.